This piece presents Ambrosus Use Case Publication about the application of Ambrosus protocol in the pharmaceutical industry, which is available to download in English. The purpose of this piece is to share findings and lessons learnt from the experimental designs and pilot projects performed by Ambrosus in the pharmaceutical sector and to outline the vision for transformation of the industry.

Pharmaceutical landscape is changing due to technological advancements, inefficient and cumbersome supply chains, as well as escalating global concern over human health problems. At the same time (and much to everyone’s indignation) general health care system is falling short of resource required to tackle a string of baseline industry challenges such as rapid population ageing, unfair distribution of essential medicines and pharmaceutical supply mismanagement.

One shortage which, in our opinion, requires immediate action is unavailability or complete non-existence of medicines that:

are affordable and easily accessible (i.e. can be purchased in local drugstores) accommodate the needs of chronic/elderly patients; can be adapted to multiple treatment plans.

For the time being, discovery and market placement of new medicines is curbed by excessive production expenses: the cost of developing an effective drug nowadays can exceed USD 2.6 billion.

Against the backdrop of unsatiated public demand, delays in deployment of new medicines inevitably lead to counterfeit. Consequently, the share of fake pharmaceuticals in the overall global supply can reach up to 15%. Taken at face value, those numbers may not seem critical or alarming. Nonetheless, consumption of counterfeit medicines causes hundreds of thousands of deaths annually. The statistics points out at a distinct fact: healthcare industry is in dire need of an end-to-end solution that could provide sufficient visibility and traceability for drug ingredients. Luckily, this much-needed solution is becoming a reality, and Ambrosus ecosystem will soon unveil it to the public.

We will remove weak links at all stages of global pharmaceutical supply chain, making the best use of Ambrosus blockchain protocol and new generation sensors. Likewise, by introducing the System of Pharmaceutical Quality Assurance we bring the entire society one step closer to accessible-for-all, cost-effective and safe pharmaceutical products.